Biogen (NASDAQ:BIIB) shares rose 1.6% on Thursday after at least two analysts weighed in positively on the outlook for the biotech giant. Raymond James analysts upgraded the rating...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more...
New York, USA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Postpartum Depression Market to Exhibit Positive Growth During the Forecast Period (2023–2032), Predicts DelveInsight | Key...
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines...
By Chuck Mikolajczak (Reuters) - The S&P 500 and Nasdaq eked out small gains on Wednesday to extend their recent winning streaks as investors weighed Federal Reserve officials'...
Today, U.S. pre-market indices recorded gains, with Dow, S&P 500, Nasdaq, and Russell 2000 all on the upswing. This marks the longest winning streak for the Dow since July....
Biogen (NASDAQ:BIIB) shares rose 1.8% in early New York trading on Wednesday after the company reported third-quarter results that topped analyst expectations. Earnings per share...